Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review

Abstract Bladder cancer is the fourth most common malignancy in males. It can present across the whole continuum of severity, from mild through well-differentiated disease to extremely malignant tumours with poor survival rates. As with other vital organ malignancies, proper clinical management invo...

Full description

Bibliographic Details
Main Authors: M. Kanmalar, Siti Fairus Abdul Sani, Nur Izzahtul Nabilla B. Kamri, Nur Akmarina B. M. Said, Amirah Hajirah B. A. Jamil, S. Kuppusamy, K. S. Mun, D. A. Bradley
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Cellular & Molecular Biology Letters
Subjects:
Online Access:https://doi.org/10.1186/s11658-022-00307-x
_version_ 1819349804993478656
author M. Kanmalar
Siti Fairus Abdul Sani
Nur Izzahtul Nabilla B. Kamri
Nur Akmarina B. M. Said
Amirah Hajirah B. A. Jamil
S. Kuppusamy
K. S. Mun
D. A. Bradley
author_facet M. Kanmalar
Siti Fairus Abdul Sani
Nur Izzahtul Nabilla B. Kamri
Nur Akmarina B. M. Said
Amirah Hajirah B. A. Jamil
S. Kuppusamy
K. S. Mun
D. A. Bradley
author_sort M. Kanmalar
collection DOAJ
description Abstract Bladder cancer is the fourth most common malignancy in males. It can present across the whole continuum of severity, from mild through well-differentiated disease to extremely malignant tumours with poor survival rates. As with other vital organ malignancies, proper clinical management involves accurate diagnosis and staging. Chemotherapy consisting of a cisplatin-based regimen is the mainstay in the management of muscle-invasive bladder cancers. Control via cisplatin-based chemotherapy is threatened by the development of chemoresistance. Intracellular cholesterol biosynthesis in bladder cancer cells is considered a contributory factor in determining the chemotherapy response. Farnesyl-diphosphate farnesyltransferase 1 (FDFT1), one of the main regulatory components in cholesterol biosynthesis, may play a role in determining sensitivity towards chemotherapy compounds in bladder cancer. FDFT1-associated molecular identification might serve as an alternative or appendage strategy for early prediction of potentially chemoresistant muscle-invasive bladder cancer tissues. This can be accomplished using Raman spectroscopy. Developments in the instrumentation have led to it becoming one of the most convenient forms of analysis, and there is a highly realistic chance that it will become an effective tool in the pathology lab. Chemosensitive bladder cancer tissues tend to have a higher lipid content, more protein genes and more cholesterol metabolites. These are believed to be associated with resistance towards bladder cancer chemotherapy. Herein, Raman peak assignments have been tabulated as an aid to indicating metabolic changes in bladder cancer tissues that are potentially correlated with FDFT1 expression.
first_indexed 2024-12-24T19:06:21Z
format Article
id doaj.art-3ae2ce7582d14fb4b98ad49a3bad6592
institution Directory Open Access Journal
issn 1425-8153
1689-1392
language English
last_indexed 2024-12-24T19:06:21Z
publishDate 2022-01-01
publisher BMC
record_format Article
series Cellular & Molecular Biology Letters
spelling doaj.art-3ae2ce7582d14fb4b98ad49a3bad65922022-12-21T16:43:05ZengBMCCellular & Molecular Biology Letters1425-81531689-13922022-01-0127112010.1186/s11658-022-00307-xRaman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a reviewM. Kanmalar0Siti Fairus Abdul Sani1Nur Izzahtul Nabilla B. Kamri2Nur Akmarina B. M. Said3Amirah Hajirah B. A. Jamil4S. Kuppusamy5K. S. Mun6D. A. Bradley7Department of Physics, Faculty of Science, University of MalayaDepartment of Physics, Faculty of Science, University of MalayaDepartment of Physics, Faculty of Science, University of MalayaDepartment of Pharmaceutical Life Sciences, Faculty of Pharmacy, University of MalayaDepartment of Pharmaceutical Life Sciences, Faculty of Pharmacy, University of MalayaDepartment of Surgery, University of MalayaDepartment of Pathology, Faculty of Medicine, University of MalayaCentre for Applied Physics and Radiation Technologies, Sunway UniversityAbstract Bladder cancer is the fourth most common malignancy in males. It can present across the whole continuum of severity, from mild through well-differentiated disease to extremely malignant tumours with poor survival rates. As with other vital organ malignancies, proper clinical management involves accurate diagnosis and staging. Chemotherapy consisting of a cisplatin-based regimen is the mainstay in the management of muscle-invasive bladder cancers. Control via cisplatin-based chemotherapy is threatened by the development of chemoresistance. Intracellular cholesterol biosynthesis in bladder cancer cells is considered a contributory factor in determining the chemotherapy response. Farnesyl-diphosphate farnesyltransferase 1 (FDFT1), one of the main regulatory components in cholesterol biosynthesis, may play a role in determining sensitivity towards chemotherapy compounds in bladder cancer. FDFT1-associated molecular identification might serve as an alternative or appendage strategy for early prediction of potentially chemoresistant muscle-invasive bladder cancer tissues. This can be accomplished using Raman spectroscopy. Developments in the instrumentation have led to it becoming one of the most convenient forms of analysis, and there is a highly realistic chance that it will become an effective tool in the pathology lab. Chemosensitive bladder cancer tissues tend to have a higher lipid content, more protein genes and more cholesterol metabolites. These are believed to be associated with resistance towards bladder cancer chemotherapy. Herein, Raman peak assignments have been tabulated as an aid to indicating metabolic changes in bladder cancer tissues that are potentially correlated with FDFT1 expression.https://doi.org/10.1186/s11658-022-00307-xBladder cancerDiagnosticFDFT1Cisplatin chemoresistanceRaman spectroscopy
spellingShingle M. Kanmalar
Siti Fairus Abdul Sani
Nur Izzahtul Nabilla B. Kamri
Nur Akmarina B. M. Said
Amirah Hajirah B. A. Jamil
S. Kuppusamy
K. S. Mun
D. A. Bradley
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
Cellular & Molecular Biology Letters
Bladder cancer
Diagnostic
FDFT1
Cisplatin chemoresistance
Raman spectroscopy
title Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
title_full Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
title_fullStr Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
title_full_unstemmed Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
title_short Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
title_sort raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by fdft1 a review
topic Bladder cancer
Diagnostic
FDFT1
Cisplatin chemoresistance
Raman spectroscopy
url https://doi.org/10.1186/s11658-022-00307-x
work_keys_str_mv AT mkanmalar ramanspectroscopybiochemicalcharacterisationofbladdercancercisplatinresistanceregulatedbyfdft1areview
AT sitifairusabdulsani ramanspectroscopybiochemicalcharacterisationofbladdercancercisplatinresistanceregulatedbyfdft1areview
AT nurizzahtulnabillabkamri ramanspectroscopybiochemicalcharacterisationofbladdercancercisplatinresistanceregulatedbyfdft1areview
AT nurakmarinabmsaid ramanspectroscopybiochemicalcharacterisationofbladdercancercisplatinresistanceregulatedbyfdft1areview
AT amirahhajirahbajamil ramanspectroscopybiochemicalcharacterisationofbladdercancercisplatinresistanceregulatedbyfdft1areview
AT skuppusamy ramanspectroscopybiochemicalcharacterisationofbladdercancercisplatinresistanceregulatedbyfdft1areview
AT ksmun ramanspectroscopybiochemicalcharacterisationofbladdercancercisplatinresistanceregulatedbyfdft1areview
AT dabradley ramanspectroscopybiochemicalcharacterisationofbladdercancercisplatinresistanceregulatedbyfdft1areview